Drug recall · January 17, 2024
Tizanidine Tablets recall
Why: Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15
- Lots / codes
Lot #: T2304007, Exp 7/31/2026
- Quantity
- 38,952 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- USA Nationwide
- Initiated
- January 2, 2024 · Voluntary: Firm initiated
- Classified
- January 11, 2024
- Reported
- January 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tizanidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.